Many people know that seemingly unrelated symptoms can be connected. But in most cases, treating individual symptoms means a separate doctor visit, sometimes to different specialists, before the full picture emerges. What if it didn’t have to be that way?
That’s the question that Hinge Health (NYSE: HNGE) is attempting to answer. It also explains why HNGE is behaving like a technology stock with a valuation to match. It’s up 91% in 2026 and has a price-to-earnings (P/E) ratio of around 69x. The question for investors is whether it’s better to be early or late.
